Doonyapat Sa-nguanraksa

Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer

Suyanee Thongchot, Niphat Jirapongwattana, Piriya Luangwattananun et al. · Molecular Cancer Therapeutics · 2022 · 43 citations · Full text

Medicine, Immunology, Oncology +17

Vascular endothelial growth factor −634G/C polymorphism is associated with increased breast cancer risk and aggressiveness

Doonyapat Sa-nguanraksa, Tuenjai Chuangsuwanich, Tawatchai Pongpruttipan et al. · Molecular Medicine Reports · 2013 · 35 citations · Full text

Medicine, Genetics, Molecular Genetics +17

High ASMA+ Fibroblasts and Low Cytoplasmic HMGB1+ Breast Cancer Cells Predict Poor Prognosis

Kamolporn Amornsupak, Pranisa Jamjuntra, Malee Warnnissorn et al. · Clinical Breast Cancer · 2017 · 34 citations

Medicine, Cancer Biology, Oncology +16

Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells

Niphat Jirapongwattana, Suyanee Thongchot, Wannasiri Chiraphapphaiboon et al. · Oncology Reports · 2022 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer

Doonyapat Sa-nguanraksa, Tuenjai Chuangsuwanich, Tawatchai Pongpruttipan et al. · Molecular and Clinical Oncology · 2015 · 21 citations · Full text

Medicine, Oncology, Pathology +17